India coronavirus diagnostics market is anticipated to show a robust growth in the upcoming five years owing to the emergence of the new strain of the virus that is rapidly spreading in the country. The market is anticipated to show an impressive double digit CAGR in the upcoming five years. Coronavirus is an infectious disease that affects the lungs of the patients and causes breathing problems. The older strains of virus in last decade were only responsible for common cold, or diseases like MERS, and SARS. In the year, 2019 the virus first spread in Wuhan, China and within next 3 months, it was announced to be the pandemic causing virus by March 2020 in the whole world. By the end of FY2021, India experienced the spread of a new strain of corona virus, the threat has increased many folds than what it was in the last year. This re-attack of the virus is directly driving the India coronavirus diagnostics market and is anticipated to do so in the next five years too.

Moreover, concerns among the Indian population regarding the threat, is driving the growth of the India coronavirus diagnostics market. Government is aiding the process of vaccination and free drives of diagnostics continuously, thereby driving the growth of the market in the upcoming five years.

India coronavirus diagnostics market is segmented by type of test, user, full time test, end user, regional distribution, and competitional landscape. Based on type of test the market is further bifurcated into molecular and serological tests. Molecular tests for the diagnosis of the coronavirus infection are anticipated to hold the larger share of the market. Molecular tests involve the tests that are done through processes like RT-PCR, CRISPR, LAMP, etc. These tests separate the viral genetic material and immediately multiply the protein encoded in the genetic material to identify the presence of virulent in human body, thereby diagnosing it. This method is often quick and takes not more than 12 to 48 hours. Thus, the segment is anticipated to dominate the market. Serological tests involve the testing of antigen and antibody in the human body. The process of generation of antigen and antibodies takes days and weeks to develop, and the identification becomes difficult until late. Serological testing is not a viable option of an active infection of COVID-19.

Some of the top players in the India coronavirus diagnostics market are, Abbott Laboratories India Ltd., Biomerieux India Private Limited, Bio-Rad Laboratories India Pvt. Ltd., DHR Holding India Pvt Ltd., Roche Diagnostics India Pvt. Ltd., Pfizer India Ltd., Mylab Discovery Solutions Pvt. Ltd., Thermo Fisher Scientific India Pvt. Ltd., CPC Diagnostics Pvt. Ltd., Zydus Cadila Ltd., among others. The companies are involving themselves into research and development for the methods of better quality, and various quality analysis tests to provide the better products.

Years considered for this report:

Historical Years: FY2017 – FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023 – FY2027

Objective of the Study:

  • To analyze the historical growth of the market size of India coronavirus diagnostics market from FY2017 to FY2020.
  • To estimate and forecast the market size of India coronavirus diagnostics market from FY2021 to FY2027 and growth rate until FY2027. 
  • To classify and forecast India coronavirus diagnostics market based on type of test, user, full test time, end user, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the India coronavirus diagnostics market.
  • To identify drivers and challenges for India coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in India coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in India coronavirus diagnostics market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of coronavirus diagnostics and other stakeholders
  • Organizations, forums, and alliances related to coronavirus diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India Coronavirus Diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Coronavirus Diagnostics Market, By Type of Test:
    • Molecular
    • Serology
  • India Coronavirus Diagnostics Market, By User:

o   Single

o   Multiple

  • India Coronavirus Diagnostics Market, By Full Test Time:
    • Less Than 60 Minutes
    • 1 Hours to 12 Hours
    • 13 Hours-24Hours
    • More Than 1 Day
  • India Coronavirus Diagnostics Market, By End User:

o   Hospitals

o   Public Health Labs

o   Private or Commercial Labs

o   Physician Labs

o   Others

  • India Coronavirus Diagnostics Market, By Region:
    • South
    • West
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Coronavirus Diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Coronavirus Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.     Product of Interest: Coronavirus Diagnostics Market

2.    Research Methodology

3.    Impact of COVID-19 on India Coronavirus Diagnostics Market

4.    Executive Summary

5.    Voice of Customers/Customer Insights

6.    India Coronavirus Diagnostics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type of Test (Molecular v/s Serology)

6.2.2.     By User (Single v/s Multiple)

6.2.3.     By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Day)

6.2.4.     By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)

6.2.5.     By Region (North, South, East, West)

6.2.6.     By Company                

6.3.  Product Market Map

7.    North India Coronavirus Diagnostics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type of Test

7.2.2.     By User

7.2.3.     By Full Test Time

7.2.4.     By End User

8.    South India Coronavirus Diagnostics Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type of Test

8.2.2.     By User

8.2.3.     By Full Test Time

8.2.4.     By End User

9.    East India Coronavirus Diagnostics Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type of Test

9.2.2.     By User

9.2.3.     By Full Test Time

9.2.4.     By End User

10.  West India Coronavirus Diagnostics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type of Test

10.2.2.  By User

10.2.3.  By Full Test Time

10.2.4.  By End User

11.  Market Dynamics

11.1.              Drivers/Opportunities

11.2.              Challenges/Restraints

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  India Economic Profile

15.  Competitive Landscape

15.1.              Company Profiles

15.1.1.  Abbott Laboratories India Ltd.

15.1.2.  Biomerieux India Private Limited

15.1.3.  Bio-Rad Laboratories India Pvt. Ltd.

15.1.4.  DHR Holding India Pvt Ltd.

15.1.5.  Roche Diagnostics India Pvt. Ltd.

15.1.6.  Pfizer India Ltd.

15.1.7.  Mylab Discovery Solutions Pvt. Ltd.

15.1.8.  Thermo Fisher Scientific India Pvt. Ltd.

15.1.9.  CPC Diagnostics Pvt. Ltd.

15.1.10.                Zydus Cadila Ltd.

16.  Strategic Recommendations

17.  About Us & Disclaimer